C A Keever Taylor

Summary

Affiliation: Medical College of Wisconsin
Country: USA

Publications

  1. ncbi request reprint Rapamycin enriches for CD4(+) CD25(+) CD27(+) Foxp3(+) regulatory T cells in ex vivo-expanded CD25-enriched products from healthy donors and patients with multiple sclerosis
    C A Keever-Taylor
    Department of Medicine Division of Neoplastic Diseases and Related Disorders, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA
    Cytotherapy 9:144-57. 2007
  2. pmc Characteristics of CliniMACS® System CD34-enriched T cell-depleted grafts in a multicenter trial for acute myeloid leukemia-Blood and Marrow Transplant Clinical Trials Network (BMT CTN) protocol 0303
    Carolyn A Keever-Taylor
    Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA
    Biol Blood Marrow Transplant 18:690-7. 2012
  3. ncbi request reprint Cytomegalovirus-specific cytolytic T-cell lines and clones generated against adenovirus-pp65-infected dendritic cells
    C A Keever-Taylor
    Department of Medicine, Medical College of Wisconsin, Milwaukee 53226, USA
    Biol Blood Marrow Transplant 7:247-56. 2001
  4. ncbi request reprint Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion
    C A Keever-Taylor
    Medical College of Wisconsin Bone Marrow Transplant Program, Department of Medicine, Milwaukee, WI 53226, USA
    Biol Blood Marrow Transplant 7:620-30. 2001
  5. pmc Stimulation by means of dendritic cells followed by Epstein-Barr virus-transformed B cells as antigen-presenting cells is more efficient than dendritic cells alone in inducing Aspergillus f16-specific cytotoxic T cell responses
    F Zhu
    Department of Medicine, Medical College of Wisconsin, Milwaukee, WI 53226, USA
    Clin Exp Immunol 151:284-96. 2008
  6. ncbi request reprint Alternative donor bone marrow transplant for children with Philadelphia chromosome ALL
    J M Talano
    Department of Pediatric Hematology, Oncology, Bone Marrow Transplant, Medical College of Wisconsin, Children s Hospital of Wisconsin, Milwaukee, WI 53226, USA
    Bone Marrow Transplant 37:135-41. 2006
  7. ncbi request reprint Loss of renal function following bone marrow transplantation: an analysis of angiotensin converting enzyme D/I polymorphism and other clinical risk factors
    M B Juckett
    Department of Medicine, Medical College of Wisconsin, Milwaukee, WI 53226, USA
    Bone Marrow Transplant 27:451-6. 2001
  8. ncbi request reprint The implication of follicular lymphoma patients receiving allogeneic stem cell transplantation from donors carrying t(14;18)-positive cells
    D K McGregor
    Department of Pathology, The Methodist Hospital, Baylor College of Medicine, 6565 Fannin Street, Houston, TX 77030, USA
    Bone Marrow Transplant 35:1049-54. 2005
  9. ncbi request reprint Complement-mediated T-cell depletion of bone marrow: comparison of T10B9.1A-31 and Muromonab-Orthoclone OKT3
    C A Keever-Taylor
    Bone Marrow Transplant Program, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI 53226, USA
    Cytotherapy 3:467-81. 2001
  10. pmc Generation of Th1 T cell responses directed to a HLA Class II restricted epitope from the Aspergillus f16 allergen
    G Ramadan
    Medical College of Wisconsin, BMT Program, Milwaukee, WI 53226, USA
    Clin Exp Immunol 139:257-67. 2005

Collaborators

Detail Information

Publications13

  1. ncbi request reprint Rapamycin enriches for CD4(+) CD25(+) CD27(+) Foxp3(+) regulatory T cells in ex vivo-expanded CD25-enriched products from healthy donors and patients with multiple sclerosis
    C A Keever-Taylor
    Department of Medicine Division of Neoplastic Diseases and Related Disorders, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA
    Cytotherapy 9:144-57. 2007
    ..Rapamycin, an agent that inhibits T-cell proliferation but selectively spares Treg, may be a means to expand Treg from less pure CD25-enriched cells...
  2. pmc Characteristics of CliniMACS® System CD34-enriched T cell-depleted grafts in a multicenter trial for acute myeloid leukemia-Blood and Marrow Transplant Clinical Trials Network (BMT CTN) protocol 0303
    Carolyn A Keever-Taylor
    Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA
    Biol Blood Marrow Transplant 18:690-7. 2012
    ..Products processed at multiple centers using the CliniMACS System for CD34 enrichment were comparably and uniformly highly enriched for CD34(+) cells, with good CD34(+) cell recovery and very low CD3(+) T cell content...
  3. ncbi request reprint Cytomegalovirus-specific cytolytic T-cell lines and clones generated against adenovirus-pp65-infected dendritic cells
    C A Keever-Taylor
    Department of Medicine, Medical College of Wisconsin, Milwaukee 53226, USA
    Biol Blood Marrow Transplant 7:247-56. 2001
    ..This approach should broaden the applicability of CMV-specific T-cell immunotherapy to a wider spectrum of patients by reducing the time required to generate CMV-specific T-cell clones...
  4. ncbi request reprint Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion
    C A Keever-Taylor
    Medical College of Wisconsin Bone Marrow Transplant Program, Department of Medicine, Milwaukee, WI 53226, USA
    Biol Blood Marrow Transplant 7:620-30. 2001
    ..Our data support the consideration of ABO match in donor selection, the preferential selection of CMV-positive donors for CMV-positive recipients, and the acceptance of 1 but not > or =2 Ag HLA MM donors...
  5. pmc Stimulation by means of dendritic cells followed by Epstein-Barr virus-transformed B cells as antigen-presenting cells is more efficient than dendritic cells alone in inducing Aspergillus f16-specific cytotoxic T cell responses
    F Zhu
    Department of Medicine, Medical College of Wisconsin, Milwaukee, WI 53226, USA
    Clin Exp Immunol 151:284-96. 2008
    ....
  6. ncbi request reprint Alternative donor bone marrow transplant for children with Philadelphia chromosome ALL
    J M Talano
    Department of Pediatric Hematology, Oncology, Bone Marrow Transplant, Medical College of Wisconsin, Children s Hospital of Wisconsin, Milwaukee, WI 53226, USA
    Bone Marrow Transplant 37:135-41. 2006
    ..Five of six patients in >CR2 or relapse at the time of transplant died. Our data should encourage the use of alternative donor transplants early in the course of disease for children with Ph+ ALL...
  7. ncbi request reprint Loss of renal function following bone marrow transplantation: an analysis of angiotensin converting enzyme D/I polymorphism and other clinical risk factors
    M B Juckett
    Department of Medicine, Medical College of Wisconsin, Milwaukee, WI 53226, USA
    Bone Marrow Transplant 27:451-6. 2001
    ..026). We conclude that the ACE genotype does not seem to influence survival, but the DD genotype may be protective against renal injury after BMT. Furthermore, we confirm that renal shielding during TBI reduces the renal injury after BMT...
  8. ncbi request reprint The implication of follicular lymphoma patients receiving allogeneic stem cell transplantation from donors carrying t(14;18)-positive cells
    D K McGregor
    Department of Pathology, The Methodist Hospital, Baylor College of Medicine, 6565 Fannin Street, Houston, TX 77030, USA
    Bone Marrow Transplant 35:1049-54. 2005
    ..It may be necessary to screen for the donor's t(14;18) status before using t(14;18) for monitoring minimal residual disease by RQ-PCR to exclude the possibility of confounding donor's t(14;18) clone...
  9. ncbi request reprint Complement-mediated T-cell depletion of bone marrow: comparison of T10B9.1A-31 and Muromonab-Orthoclone OKT3
    C A Keever-Taylor
    Bone Marrow Transplant Program, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI 53226, USA
    Cytotherapy 3:467-81. 2001
    ..Cobe Spectra cannot be used for BMMC processing with OKT3, fewer CD34(+) are therefore infused. Technical, as well as biological, differences between narrow specificity MAbs can affect graft outcome...
  10. pmc Generation of Th1 T cell responses directed to a HLA Class II restricted epitope from the Aspergillus f16 allergen
    G Ramadan
    Medical College of Wisconsin, BMT Program, Milwaukee, WI 53226, USA
    Clin Exp Immunol 139:257-67. 2005
    ....
  11. ncbi request reprint Suppression of EBV release from irradiated B lymphoblastoid cell-lines: superior activity of ganciclovir compared with acyclovir
    C A Keever-Taylor
    Department of Medicine Division of Neoplastic Diseases, Medical College of Wisconsin, WI 53226, USA
    Cytotherapy 5:323-35. 2003
    ..We tested the effectiveness of ACV in preventing the release of infectious virus from irradiated fresh and previously frozen BLCL, and compared its effects with those of ganciclovir (GCV)...
  12. ncbi request reprint Factors affecting neutrophil and platelet reconstitution following T cell-depleted bone marrow transplantation: differential effects of growth factor type and role of CD34(+) cell dose
    C A Keever-Taylor
    Bone Marrow Transplant Program, Medical College of Wisconsin, Milwaukee, WI, USA
    Bone Marrow Transplant 27:791-800. 2001
    ....
  13. ncbi request reprint Generation of Aspergillus- and CMV- specific T-cell responses using autologous fast DC
    G Ramadan
    Medical College of Wisconsin, BMT Program, Milwaukee, WI 53226, USA
    Cytotherapy 6:223-34. 2004
    ..Here we assess the efficacy of the fast-DC to process and present different Aspergillus fumigatus and CMV Ag preparations to autologous T cells, compared with DCs generated in standard 7-day cultures (standard-DC)...